| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $29.92 | $11,968.00 | -2.7% | -4.0% | -58.3% | |
| Sep 10, 2021 | Christine Ring75 | General Counsel | Sale+OE | 2,000 | $35.93 | $71,860.17 | -60.9% | -19.2% | -55.7% | |
| Sep 7, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,600 | $35.00 | $56,000.00 | -10.1% | -21.2% | -54.2% | |
| Sep 7, 2021 | Christine Ring75 | General Counsel | Sale+OE | 3,200 | $35.25 | $112,800.00 | -71.3% | -21.2% | -54.2% | |
| Sep 1, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $32.34 | $12,936.00 | -2.7% | -9.8% | -48.7% | |
| Aug 10, 2021 | Pierre Beaurang64 | Chief Business Officer | Sale+OE | 7,500 | $29.86 | $223,925.93 | -63.4% | +10.2% | -34.7% | |
| Aug 10, 2021 | Christine Ring75 | General Counsel | Sale+OE | 1,200 | $29.87 | $35,844.96 | -59.9% | +10.2% | -34.7% | |
| Aug 2, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $31.21 | $12,484.00 | -2.8% | +8.1% | -48.1% | |
| Jul 20, 2021 | Christine Ring75 | General Counsel | Sale+OE | 1,200 | $27.00 | $32,400.00 | -59.9% | -1.2% | -40.9% | |
| Jul 12, 2021 | Pierre Beaurang64 | Chief Business Officer | Sale+OE | 7,500 | $23.92 | $179,418.70 | -63.4% | +17.2% | -33.2% |